CareDx Ownership | Who Owns CareDx?
CareDx Ownership Summary
CareDx is owned by 59.98% institutional investors, 3.81% insiders, and 36.21% retail investors. Blackrock is the largest institutional shareholder, holding 10.13% of CDNA shares. Bellevue Healthcare Ord is the top mutual fund, with 6.13% of its assets in CareDx shares.
CDNA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | CareDx | 59.98% | 3.81% | 36.21% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Diagnostics & Research Stocks | 49.06% | 8.59% | 42.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 5.29M | 10.13% | $82.10M |
Blackrock funding, inc. /de | 5.09M | 9.61% | $108.89M |
Vanguard group | 4.86M | 9.19% | $104.05M |
State street | 2.66M | 5.03% | $56.93M |
Ark investment management | 2.41M | 4.55% | $51.58M |
Bamco inc /ny/ | 2.21M | 4.17% | $47.26M |
Fred alger management | 1.61M | 3.05% | $34.56M |
Invesco | 1.51M | 2.86% | $32.43M |
Nikko asset management americas | 1.50M | 2.83% | $32.01M |
Sumitomo mitsui trust | 1.50M | 2.83% | $32.07M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Blue water life science advisors, lp | 604.00K | 11.45% | $12.93M |
Gagnon securities | 1.43M | 6.17% | $30.64M |
Gagnon advisors | 412.88K | 5.66% | $8.84M |
Bullseye asset management | 182.49K | 1.84% | $3.91M |
Divisadero street capital management, lp | 711.76K | 1.78% | $15.24M |
Intrinsic edge capital management | 255.00K | 0.66% | $5.46M |
Virtus investment advisers | 36.34K | 0.61% | $778.00K |
Bellevue group | 1.37M | 0.57% | $29.43M |
Formula growth | 78.00K | 0.57% | $1.67M |
Prosight management, lp | 80.00K | 0.47% | $1.71M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Divisadero street capital management, lp | 711.76K | 1.78% | 711.76K |
State street | 2.66M | 0.00% | 623.01K |
Macquarie group | 441.21K | 0.01% | 441.21K |
Goldman sachs group | 939.51K | 0.00% | 434.74K |
Bamco inc /ny/ | 2.21M | 0.12% | 330.63K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bellevue group | 1.37M | 0.57% | -1.77M |
Ark investment management | 2.41M | 0.43% | -579.50K |
Fmr | 81.85K | 0.00% | -543.70K |
Bank of montreal /can/ | 10.63K | 0.00% | -382.19K |
Boston partners | 21.30K | 0.00% | -353.84K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Divisadero street capital management, lp | 711.76K | 1.78% | 711.76K | $15.24M |
Macquarie group | 441.21K | 0.01% | 441.21K | $9.45M |
Next century growth investors | 219.75K | 0.35% | 219.75K | $4.70M |
Raymond james financial | 172.56K | 0.00% | 172.56K | $3.69M |
Capital fund management | 123.00K | 0.01% | 123.00K | $2.63M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -11.00 |
Innealta capital | -13.00 |
Smartleaf asset management | -27.00 |
Bessemer group | -45.00 |
Venturi wealth management | -160.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 129 | -41.10% | 31,732,233 | -38.55% | 59 | 0.63% | 78 | -43.07% | 26 | -53.57% |
Sep 30, 2024 | 219 | 40.38% | 51,642,047 | -3.42% | 97 | 0.93% | 139 | 71.60% | 55 | -5.17% |
Jun 30, 2024 | 156 | 4.70% | 53,469,341 | -2.95% | 102 | 0.90% | 81 | 24.62% | 58 | -1.69% |
Mar 31, 2024 | 149 | - | 55,095,521 | 2.76% | 106 | 1.06% | 65 | -8.45% | 59 | 7.27% |
Dec 31, 2023 | 149 | -1.32% | 53,615,354 | -4.02% | 100 | 0.94% | 71 | 1.43% | 55 | -8.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Bellevue Healthcare Ord | 3.23M | 6.13% | 3.23M |
ARK Genomic Revolution | 2.38M | 4.43% | -591.82K |
ARK Genomic Revolution ETF | 2.26M | 4.07% | 87.05K |
Baron Discovery Strategy | 1.68M | 3.03% | - |
Baron Discovery Institutional | 1.68M | 3.03% | - |
Vanguard Total Stock Mkt Idx Inv | 1.60M | 2.88% | - |
Vanguard US Total Market Shares ETF | 1.52M | 2.74% | -168.20K |
iShares Russell 2000 ETF | 1.36M | 2.45% | -11.77K |
Alger Small Cap Focus I | 1.22M | 2.21% | - |
Alger Small Cap Focus Composite | 1.22M | 2.21% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 07, 2025 | Jain Abhishek | Chief Financial Officer | Sell | $4.70K |
Apr 07, 2025 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | $16.37K |
Mar 10, 2025 | Bickerstaff George | - | Sell | $367.10K |
Feb 04, 2025 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | $81.83K |
Dec 04, 2024 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | $49.84K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 2 |
2025 Q1 | - | 2 |
2024 Q4 | - | 7 |
2024 Q3 | - | 8 |
2024 Q2 | - | - |
CDNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools